Fund Holdings — BIOS Capital Management, LP

Total Portfolio Value
$82.62M
Total Bought
$593.0K
Total Sold
$1.98M
Net Transaction
-$1.39M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
OPUS GENETICS INC(IRD)3,683,4293,683,42906,5937,4048.96%+810
IN8BIO INC0253,417+253,41705930.72%+593
REIN THERAPEUTICS INC(RNTX)1,690,7511,690,75101,9441,9612.37%+17
COGNITION THERAPEUTICS INC(CGTX)6,000,0006,000,00008,1008,1009.80%0
IN8BIO INC286,6640-286,6646220—-622
LANTERN PHARMA INC(LTRN)1,015,7151,009,507-6,2084,4183,0593.70%-1,360
ACTUATE THERAPEUTICS INC10,049,99610,049,996067,23461,50674.44%-5,728
Page 1 of 1
BIOS Capital Management, LP — 13F Holdings — Q4 2025 | TickerTrail